These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 20218745)
1. Current approaches to the management of pediatric Hodgkin lymphoma. Freed J; Kelly KM Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745 [TBL] [Abstract][Full Text] [Related]
2. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation. Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639 [TBL] [Abstract][Full Text] [Related]
3. Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma. Paudel N; Schulze D; Gentzler RD; Evens AM; Helenowski I; Dillehay G; Frankfurt O; Mehta J; Donnelly ED; Gordon LI; Winter JN; Mittal BB Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):436-446. PubMed ID: 30763660 [TBL] [Abstract][Full Text] [Related]
4. A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03). Wirth A; Prince HM; Roos D; Gibson J; O'Brien P; Zannino D; Khodr B; Stone JM; Davis S; Hertzberg M Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1158-1166. PubMed ID: 30553941 [TBL] [Abstract][Full Text] [Related]
5. Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients. Zinzani PL; Pellegrini C; Cantonetti M; Re A; Pinto A; Pavone V; Rigacci L; Celli M; Broccoli A; Argnani L; Pulsoni A Oncologist; 2015 Dec; 20(12):1413-6. PubMed ID: 26500229 [TBL] [Abstract][Full Text] [Related]
6. F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma. Gentzler RD; Evens AM; Rademaker AW; Weitner BB; Mittal BB; Dillehay GL; Petrich AM; Altman JK; Frankfurt O; Variakojis D; Singhal S; Mehta J; Williams S; Kaminer L; Gordon LI; Winter JN Br J Haematol; 2014 Jun; 165(6):793-800. PubMed ID: 24628515 [TBL] [Abstract][Full Text] [Related]
7. Recent treatment advances in Hodgkin lymphoma: a concise review. Arulogun S; Hertzberg M; Gandhi MK Intern Med J; 2016 Dec; 46(12):1364-1369. PubMed ID: 26929077 [TBL] [Abstract][Full Text] [Related]
8. Successful outcome of patients with relapsed/refractor Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St. James's Hospital. Bacon CL; Daly P; Sheane B; Conneally EC; Browne PV; McCann S; Ni Chongaile M; O'Brian DS; Mc Dermott R; Hollywood D; Wilson L; Vandenberghe E Ir Med J; 2009 Jan; 102(1):26-8. PubMed ID: 19284016 [TBL] [Abstract][Full Text] [Related]
9. Hodgkin Lymphoma: Diagnosis and Treatment. Ansell SM Mayo Clin Proc; 2015 Nov; 90(11):1574-83. PubMed ID: 26541251 [TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
12. Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study. Zinzani PL; Broccoli A; Gioia DM; Castagnoli A; Ciccone G; Evangelista A; Santoro A; Ricardi U; Bonfichi M; Brusamolino E; Rossi G; Anastasia A; Zaja F; Vitolo U; Pavone V; Pulsoni A; Rigacci L; Gaidano G; Stelitano C; Salvi F; Rusconi C; Tani M; Freilone R; Pregno P; Borsatti E; Sacchetti GM; Argnani L; Levis A J Clin Oncol; 2016 Apr; 34(12):1376-85. PubMed ID: 26884559 [TBL] [Abstract][Full Text] [Related]
13. Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival. Sucak GT; Özkurt ZN; Suyani E; Yaşar DG; Akdemir ÖÜ; Aki Z; Yeğin ZA; Yağci M; Kapucu ÖL Ann Hematol; 2011 Nov; 90(11):1329-36. PubMed ID: 21437590 [TBL] [Abstract][Full Text] [Related]
14. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma. Akhtar S; Rauf SM; Elhassan TA; Maghfoor I Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363 [TBL] [Abstract][Full Text] [Related]
15. Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation. Shah GL; Yahalom J; Matasar MJ; Verwys SL; Goldman DA; Bantilan KS; Zhang Z; McCall SJ; Moskowitz AJ; Moskowitz CH Br J Haematol; 2016 Nov; 175(3):440-447. PubMed ID: 27377168 [TBL] [Abstract][Full Text] [Related]
17. [Novel treatment options in relapsed and refracter Hodgkin lymphomas]. Illés Á; Jóna Á; Simon Z; Udvardy M; Miltényi Z Orv Hetil; 2015 Nov; 156(45):1824-33. PubMed ID: 26522856 [TBL] [Abstract][Full Text] [Related]
18. High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma. Persky DO; Moskowitz CH; Filatov A; Saxena R; Cui H; Teruya-Feldstein J Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):35-40. PubMed ID: 19701081 [TBL] [Abstract][Full Text] [Related]
19. Stem cell transplantation in Hodgkin lymphoma. Reddy NM; Perales MA Hematol Oncol Clin North Am; 2014 Dec; 28(6):1097-112. PubMed ID: 25459181 [TBL] [Abstract][Full Text] [Related]
20. Patterns of Relapse After Salvage Autologous Stem Cell Transplant for Hodgkin's Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to Guide Indications for Peri-Transplant Radiation Therapy. Farris JC; Ritter A; Craig MD; Shah N; Veltri L; Kanate AS; Ross K; Vargo JA Pract Radiat Oncol; 2019 May; 9(3):e290-e297. PubMed ID: 30579808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]